P50 component of auditory evoked potentials in persons with schizophrenia and their first degree relatives;Składowa P50 słuchowych potenejałów wywołanych u chorych na schizofreniȩ i ich krewnych pierwszego stopnia

Psychiatria Polska

Volumn 38, Issue 3, 2004, Pages 395-408

  Wȩgrzyn, Jacek ^a,b   Wciórka, Jacek ^a  

^a III Klinika IPiN   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

First order relatives; P50 AEP; Patients; Schizophrenia

Indexed keywords

AMPLITUDE MODULATION; ARTICLE; AUDITORY STIMULATION; BRAIN ELECTROPHYSIOLOGY; CHANNEL GATING; CLINICAL ARTICLE; CONTROLLED STUDY; EVOKED AUDITORY RESPONSE; EYE MOVEMENT; FAMILY HISTORY; HUMAN; MASTOID; NEUROPHYSIOLOGY; RELATIVE; SCHIZOPHRENIA; SELF REPORT; SOUND INTENSITY;

ACOUSTIC STIMULATION; ADULT; CASE-CONTROL STUDIES; EVOKED POTENTIALS, AUDITORY; FAMILY; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLAND; REFERENCE VALUES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 3042666210     PISSN: 00332674     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Venables PH. Input dysfunction in schizophrenia. W: Maher BA, red. Progress in experimental personality research. Vol. 1. New York: Academic Press; 1964, s. 1-48.
2. Ecless JC. The inhibitory pathways of the central nervous system. Springfield, IL: Charles C. Thomas; 1969.
3. Adler LE, Rose GM, Freedman R. Neurophysiological studies of sensory gating in rats: effect of amphetamine, phencyclidyne, and haloperidol. Biol. Psychiatry 1986; 21: 787-798.
4. Siegel C, Waldo M, Mizner G, Adler LE, Freedman R. Deficits in sensory gating in schizophrenic patients and their relatives. Evidence obtained with auditory evoked responses. Arch. Gen. Psychiatry 1984; 41: 6607-6612.
5. Adler LE, Pachtman E, Franks RD, Pecevich M, Waldo MC, Freedman R. Neurophysiological evidence for a defect in neuronal mechanisms in sensory gating in schizophrenia. Biol. Psychiatry 1982; 17: 639-654.
6. Freedman R, Adler LE, Waldo MC, Pachtman E, Franks RD. Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparision of medicated and drug free patients. Biol. Psychiatry 1983; 18: 537-551.
7. Nagamoto HT, Adler LE, Waldo MC, Griffith J, Freedman R. Gating of auditory response in schizophrenics and normal controls. Effects of recording site and stimulation interval on the P50 wave. Schiz. Res. 1991; 4: 31-40.
8. Hetrick WP, Sandman CA, Bunney WE jr, Jin Y, Potkin SG, White MH. Gender differences in gating of the auditory evoked potential in normal subjects. Biol. Psychiatry 1996; 1, 39: 151-158.
9. Jerger K, Biggins Ch, Fein G. P50 supression is not affected by attentional manipulations. Biol. Psychiatry 1992; 31: 365-377.
10. Cardenas VA, Gill P, Fein G. Human P50 suppression is not affected by variations in wakeful alertness. Biol. Psychiatry 1997; 15, 41: 8891-8901.
11. Vinogradova O. Functional organisation of the limbic system in the process of registration of information. W: Isaacson RL, Pribram KH, red. The hippocampus: neurophysiology and behavior. Vol. 1. New York, NY: Plenum Press; 1975, s. 3-69.
12. Bickford-Wimer P, Nagamoto H, Johnson R, Adler LE, Egan M, Rose GM, Freedman R. Auditory sensory gating in hippocampal neuron: a model system in the rat. Biol. Psychiatry 1990; 27: 183-192.
13. Simpson GV, Knight RT. Multiple brain systems generating the rat auditory evoked potential: II. Dissociation of auditory cortex and nonlemniscal generator systems. Brain Research 1993; 602: 251-263.
14. Luntz-Leybman V, Bickford PC, Freedman R. Cholinergic gating of response to auditory stimuli in rat hipocampus. Brain Research 1992; 587: 130-136.
15. Freedman R, Wetmore C, Stromberg I, Leonard S, Olson L. a-Bungarotoxin binding to hippocampal interneurons: immunocytochemical characterization and effect on growth factor expression. J. Neurosc. 1993; 13: 1965-1975.
16. Freedman R, Hall M, Adler LE, Leonard S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol. Psychiatry 1995; 38: 22-33.
17. Miller C, Freedman R. The activity of hippocampal interneurons and pyramidal cells during the response of the hippocampus to repeated auditory stimuli. Neurosc. 1995; 69: 371-381.
18. Adler LE, Olincy A, Waldo M, Harris JG, Griffith J, Stevens K, Flach K, Nagamoto H, Bickford P, Leonard S, Freedman R. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr. Bull. 1998; 24: 2189-2202.
19. Leonard S, Adams C, Breese CR, Adler LE, Bickford P, Byerley W, Coon H, Griffith JM, Miller C, Myles-Worsley M, Nagamoto HT, Rollins Y, Stevens KE, Waldo M, Freedman R. Nicotinic receptor function in schizophrenia. Schizophr. Bull. 1996; 22: 3431-3445.
20. Baker NJ, Staunton M, Adler LE, Gerhardt GA, Drebing C, Waldo M, Nagamoto H, Freedman R. Sensory gating deficits in psychiatric inpatients: relation to catecholamine metabolites in different diagnostic groups. Biol. Psychiatry 1990; 1, 27: 5519-5528.
21. Braff DL, Geyer MA. Sensorimotor gating and schizophrenia. Human and animal model studies. Arch. Gen. Psychiatry 1990; 47: 181-188.
22. Freedman R, Adler LE, Myles-Worsley M, Nagamoto HT, Miller C, Kisley M, McRae K, Cawthra E, Waldo M. Inhibitory gating of an evoked response to repeated auditory stimuli in schizophrenic and normal subjects. Human recordings, computer simulation, and an animal model. Arch. Gen. Psychiatry 1996; 53: 121114-121121.
23. Boutros NN, Zouridakis G, Overall J. Replication and extension of P50 findings in schizophrenia. Clin. Electroencephalogr. 1991; 22: 140-145.
24. Ward PB, Hoffer LD, Liebert BJ, Catts SV, O'Donnell M, Adler LE. Replication of a P50 auditory gating deficit in Australian patients with schizophrenia. Psychiatry Res. 1996; 27, 64: 2121-2135.
25. Judd LL, McAdams L, Budnick B, Braff DL. Sensory gating deficits in schizophrenia: new results. Am. J. Psychiatry 1992; 149: 4488-4493.
26. Freedman R, Waldo M, Bickford-Wimer P, Nagamoto H. Elementary neuronal dysfunctions in schizophrenia. Schiz. Res. 1991; 4: 233-243.
27. Nagamoto HT, Adler LE, Waldo MC, Freedman R. Sensory gating in schizophrenics and normal controls: effect of changing stimulation interval. Biol. Psychiatry 1989; 25: 549-561.
28. Franks RD, Adler LE, Waldo MC, Alpert J, Freedman R. Neurophysiological studies of sensory gating in mania: comparision with schizophrenia. Biol. Psychiatry 1983; 18: 989-1005.
29. Baker N, Adler LE, Franks RD, Waldo M, Berry S, Nagamoto H, Muckle A, Freedman R. Neurophysiological assessment of sensory gating in psychiatric inpatients: comparison between schizophrenia and other diagnoses. Biol. Psychiatry 1987; 22: 5603-5617.
30. Boutros N, Zouridakis G, Rustin T, Peabody C, Warner D. The P50 component of the auditory evokedpotential and subtypes of schizophrenia. Psychiatry Res. 1993; 47: 3243-3254.
31. Adler LE, Gerhardt GA, Franks R, Baker N, Nagamoto H, Drebing C, Freedman R. Sensory physiology and catecholamines in schizophrenia and mania. Psychiatr. Res. 1989; 31: 297-309.
32. Adler LE, Hoffer LD, Wieser A, Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am. J. Psychiatry 1993; 150: 121856-121861.
33. Adler LE, Hoffer LJ, Griffith J, Waldo MC, Freedman R. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol. Psychiatry 1992; 1, 32: 7607-7616.
34. Waldo MC, Carey G, Myles-Worsley M, Cawthra E, Adler LE, Nagamoto HT, Wender P, Byerley W, Plaetke R, Freedman R. Codistribution of a sensory gating deficit and schizophrenia in multi-affected families. Psychiatry Res. 1991; 39: 3257-3268.
35. Young DA, Waldo M, Rutledge JH 3rd, Freedman R. Heritability of inhibitory gating of the P50 auditory-evoked potential in monozygotic and dizygotic twins. Neuropsychobiol. 1996; 33: 3113-3117.
36. Cadenhead KS, Light GA, Geyer MA, Braff DL. Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. Am. J. Psychiatry 2000; 157: 155-159.
37. Meehl PE. Schizotaxia, schizotypy, schizophrenia. Am. Psychol. 1962; 17: 827-838.
38. Clementz BA, Geyer MA, Braff DL. Multiple site evaluation of P50 suppresion among schizophrenia and normal comparision subjects. Schiz. Res. 1998; 27, 30 (1): 71-80.
39. Kathmann N, Engel RR. Sensory gating in normals and schizophrenics: a failure to find strong P50 suppresion in normals. Biol. Psychiatry 1990; 27: 1216-1226.
40. Bramon E, Stagias K, Croft RJ, McDonald C, Murray RM. The P50 wave in schizophrenia: a family study. Schizophr. Res. 2002; 53(supl. 3): 216.
41. Light GA, Braff DL. The "incredible shrinking" P50 event-related potential. Biol. Psychiatry 1998; 15, 43: 12918-12920.
42. Jin Y, Potkin SG, Patterson JV, Sandman CA, Hetrick WP, Bunney WE. Effects of P50 temporal variability on sensory gating in schizophrenia. J. Psychiatry Res. 1997; 5, 70: 271-281.
43. Waldo MC, Cawthra E, Adler LE, Dubester S, Staunton M, Nagamoto H, Baker N, Madison A, Simon J, Scherzinger A, Drebing C, Gerhardt G, Freedman R. Auditory sensory gating, hippocampal volume, and catecholamine metabolism in schizophrenics and their siblings. Schiz. Res. 1994; 12: 93-106.
44. Freedman R, Mirsky AF. Event related potentials: exogenous components. W: Nasrallah HA, red. Handbook of schizophrenia. Vol. 5. Amsterdam, London, New York, Tokyo: Elsevier; 1991, s. 71-90.
45. Griffith J, Hoffer LD, Adler LE, Zerbe GO, Freedman R. Effects of sound intensity on a midlatency evoked response to repeated auditory stimuli in schizophrenic and normal subjects. Psychophysiol. 1995; 32: 5460-5466.
46. Nagamoto HT, Adler LE, Hea RA, Griffith JM, McRae KA, Freedman R. Gating of auditory P50 in schizophrenics: unique effects of clozapine. Biol. Psychiatry 1996; 1, 40: 3181-3188.
47. Light GA, Geyer MA, Clementz BA, Cadenhead KS, Braff DL. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications. Am. J. Psychiatry 2000; 157: 5767-5771.